Filing Details
- Accession Number:
- 0001104659-21-143551
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-24 16:06:28
- Reporting Period:
- 2021-11-23
- Accepted Time:
- 2021-11-24 16:06:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1736243 | Acurx Pharmaceuticals Inc. | ACXP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1854182 | Carl Sailer | C/O Acurx Pharmaceuticals, Inc., 259 Liberty Avenue Staten Island NY 10305 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-23 | 5,161 | $4.84 | 73,078 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,000 | Indirect | By Spouse |
Footnotes
- The price reflects the average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $4.73 to $4.86 per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price.